- Home
- ELDN vs IDR Comparison
ELDN vs IDR Comparison
Compare ELDN & IDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELDN
- IDR
- Stock Information
- Founded
- ELDN 2004
- IDR 1996
- Country
- ELDN United States
- IDR United States
- Employees
- ELDN N/A
- IDR N/A
- Industry
- ELDN Biotechnology: Pharmaceutical Preparations
- IDR Precious Metals
- Sector
- ELDN Health Care
- IDR Basic Materials
- Exchange
- ELDN Nasdaq
- IDR Nasdaq
- Market Cap
- ELDN 140.3M
- IDR 150.0M
- IPO Year
- ELDN N/A
- IDR N/A
- Fundamental
- Price
- ELDN $4.07
- IDR $11.94
- Analyst Decision
- ELDN Strong Buy
- IDR Strong Buy
- Analyst Count
- ELDN 1
- IDR 1
- Target Price
- ELDN $16.00
- IDR $14.00
- AVG Volume (30 Days)
- ELDN 1.0M
- IDR 317.5K
- Earning Date
- ELDN 11-12-2024
- IDR 11-04-2024
- Dividend Yield
- ELDN N/A
- IDR N/A
- EPS Growth
- ELDN N/A
- IDR 344.27
- EPS
- ELDN N/A
- IDR 0.52
- Revenue
- ELDN N/A
- IDR $21,955,008.00
- Revenue This Year
- ELDN N/A
- IDR $100.42
- Revenue Next Year
- ELDN N/A
- IDR $4.80
- P/E Ratio
- ELDN N/A
- IDR $22.85
- Revenue Growth
- ELDN N/A
- IDR 64.93
- 52 Week Low
- ELDN $1.11
- IDR $5.46
- 52 Week High
- ELDN $5.54
- IDR $18.35
- Technical
- Relative Strength Index (RSI)
- ELDN 51.95
- IDR 39.63
- Support Level
- ELDN $3.76
- IDR $10.92
- Resistance Level
- ELDN $4.17
- IDR $12.82
- Average True Range (ATR)
- ELDN 0.39
- IDR 1.15
- MACD
- ELDN -0.15
- IDR -0.09
- Stochastic Oscillator
- ELDN 18.45
- IDR 24.25
About ELDN Eledon Pharmaceuticals Inc.
Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. The company's compound in development is tegoprubart, an IgG1, anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.
About IDR Idaho Strategic Resources Inc.
Idaho Strategic Resources Inc is a vertically integrated, operating junior mining company. It produces gold at the Golden Chest Mine. In addition to gold and gold production, the company maintains a strategic and domestic presence in the Critical Minerals sector and is focused on advancing its officially recognized Lemhi Pass, Diamond Creek, and Roberts Rare Earth Element projects in central Idaho.